A photo of Hannah Fry and Michael Stevens.

The Rest Is Science

We’re partnering with The Rest Is Science in a podcast series where curiosity meets discovery.

About the series

The Rest Is Science brings together mathematician Professor Hannah Fry and YouTuber Michael Stevens (aka Vsauce) to explore the wonders of science. Over the past 50 years, our pioneering work has helped double cancer survival in the UK. With our help, The Rest Is Science explores some of the research that is driving a revolution in our understanding of cancer and our ability to beat it.

Our special bonus episode

In this special episode of The Rest Is Science, Professor Hannah Fry and Michael Stevens speak to our chief clinician, Professor Mariam Jamal-Hanjani, about some of the biggest unanswered questions in cancer research. Hannah shares her experience with cervical cancer and her optimism about the HPV (human papillomavirus) vaccine. Read more about our progress in beating cervical cancer

Meet our chief clinician

Portrait of researcher Mariam Jamal-Hanjani.

The latest science from the series

Explore the cutting-edge cancer research featured this month on The Rest Is Science.

In the 1990s, our scientists helped discover the BRCA1 and BRCA2 genes, which increase our cancer risk if they’re faulty. This groundbreaking research revolutionised how we prevent, detect and treat cancers linked to these genes. 

Want to learn more?

Discover more of the cancer research featured across The Rest Is Science. 

Superresolution image of a group of killer T cells (green and red) surrounding a cancer cell.

Beating cancer with CAR T-cell therapy

CAR T-cell therapy is a powerful cancer treatment that helps the immune system detect and fight cancer. Our researchers are working to improve CAR T-cell therapy for children and young people, so the modified immune cells can keep hunting down and destroying cancer cells for longer.

Close up of a microscopic allergy drug.

Shrinking tumours using the science behind allergies

Our scientists discovered that we could use our immune system’s allergic reactions against cancer. They’ve built on their discovery and developed a drug that’s shown promise in shrinking tumours in the lab, opening the door to new allergy-inspired cancer treatment.

Watch more episodes on YouTube

Other ways to listen

Listen on Apple podcasts Listen on Spotify